Healthcare utilization and medical expenditure of Korean psoriasis patients: A descriptive result using a health insurance database
- PMID: 29901614
- PMCID: PMC6024228
- DOI: 10.1097/MD.0000000000011070
Healthcare utilization and medical expenditure of Korean psoriasis patients: A descriptive result using a health insurance database
Abstract
Background: Epidemiological evidence regarding healthcare utilization and medical expenditure of patients with psoriasis in Korea is needed. To analyze the differences in healthcare utilization and financial burdens between patients with and without psoriasis and compare these patterns according to the disease severity.
Methods: We conducted a descriptive cross-sectional study using a sample of the National Health Insurance database between January 1, 2012 and December 31, 2013. We included patients diagnosed with psoriasis and those with nonpsoriasis skin diseases, matched for age, sex, income, and geographical region. The patients with psoriasis were further divided into mild and moderate-to-severe psoriasis groups. Each patient was followed up for 1 year to estimate their healthcare utilization and medical expenditure since their initial diagnosis. Healthcare utilization was defined as the sum of outpatient visits and inpatient stays per person. We conducted McNemar test or Bowker test of symmetry to compare the baseline characteristics and used the Wilcoxon matched-pair signed-rank test to compare the healthcare utilization and direct costs with a 5% significance level.
Results: Our study subjects were 4016 patients with psoriasis and equally matched 4016 patients with nonpsoriasis skin diseases. Compared with patients without psoriasis, those with psoriasis had more days of healthcare service use (5.26 vs 4.19, P < .001) and higher medical expenditures within 1 year per person (209,320 vs 117,968 won, P < .001). Patients with moderate-to-severe psoriasis had more days of healthcare service use (12.71 vs 3.25, P < .001) and higher medical expenditures within 1 year per person (611,688 vs 107,445 won, P < .001) than those with mild psoriasis.
Conclusion: Patients with psoriasis had higher burdens of healthcare utilization than those without psoriasis, and patients with moderate-to-severe psoriasis had the greatest burdens.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Similar articles
-
Comparison of out-of-pocket expenditure and catastrophic health expenditure for severe disease by the health security system: based on end-stage renal disease in South Korea.Int J Equity Health. 2021 Jan 6;20(1):6. doi: 10.1186/s12939-020-01311-3. Int J Equity Health. 2021. PMID: 33407535 Free PMC article.
-
Incremental Healthcare Service Utilization for Open-angle Glaucoma: A Population-Based Study.J Glaucoma. 2015 Jun-Jul;24(5):e116-20. doi: 10.1097/IJG.0000000000000222. J Glaucoma. 2015. PMID: 25642815
-
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis.J Med Econ. 2017 Sep;20(9):982-990. doi: 10.1080/13696998.2017.1345749. Epub 2017 Jul 11. J Med Econ. 2017. PMID: 28635342
-
Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan.J Dermatolog Treat. 2017 Nov;28(7):613-622. doi: 10.1080/09546634.2017.1303566. Epub 2017 Mar 20. J Dermatolog Treat. 2017. PMID: 28320213
-
Healthcare resource utilization and costs among psoriasis patients treated with biologics, overall and by disease severity.J Med Econ. 2018 Aug;21(8):745-754. doi: 10.1080/13696998.2018.1472097. Epub 2018 May 22. J Med Econ. 2018. PMID: 29718756
Cited by
-
Uncovering the unmet needs among psoriasis patients in the Asia-Pacific region.J Dermatol. 2021 Nov;48(11):1665-1674. doi: 10.1111/1346-8138.16072. Epub 2021 Jul 27. J Dermatol. 2021. PMID: 34318497 Free PMC article.
References
-
- World Health Organization. Global report on psoriasis. 2016. Available at: http://apps.who.int/iris/bitstream/handle/10665/204417/9789241565189_eng.... Accessed March 2016.
-
- Heller MM, Wong JW, Nguyen TV, et al. Quality-of-life instruments: evaluation of the impact of psoriasis on patients. Dermatol Clin 2012;30:281–91. - PubMed
-
- Lowes MA, Bowcock AM, Krueger JG. Pathogenesis and therapy of psoriasis. Nature 2007;445:866–73. - PubMed
-
- The Korean Society for Psoriasis. Managing comorbid disease in patients with psoriasis. 2015. Available at: http://www.kspder.or.kr/en/. Accessed December 3, 2016.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical